Switch theme
Sign up to access all valuation multiples
Farminveste SGPS SA is a holding company and its subsidiaries are active in the business of pharmacies, pharmaceutical distribution, information systems, health care, real estate, market intelligence and other services.
2010
6
LTM Revenue n/a
LTM EBITDA n/a
$275M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Farminveste SGPS has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Farminveste SGPS achieved revenue of $955M and an EBITDA of $59.3M.
Farminveste SGPS expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Farminveste SGPS valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $935M | $955M | XXX | XXX | XXX |
| Gross Profit | $198M | $204M | XXX | XXX | XXX |
| Gross Margin | 21% | 21% | XXX | XXX | XXX |
| EBITDA | $47.4M | $59.3M | XXX | XXX | XXX |
| EBITDA Margin | 5% | 6% | XXX | XXX | XXX |
| Net Profit | $2.2M | $4.1M | XXX | XXX | XXX |
| Net Margin | 0% | 0% | XXX | XXX | XXX |
| Net Debt | $274M | $276M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 13, 2025, Farminveste SGPS's stock price is EUR 1 (or $1).
Farminveste SGPS has current market cap of EUR 23.4M (or $26.3M), and EV of EUR 244M (or $275M).
See Farminveste SGPS trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $275M | $26.3M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 13, 2025, Farminveste SGPS has market cap of $26.3M and EV of $275M.
Farminveste SGPS's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Farminveste SGPS's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Farminveste SGPS and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $275M | XXX | XXX | XXX |
| EV/Revenue | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | 4.6x | XXX | XXX | XXX |
| P/E | 2.3x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 6.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialFarminveste SGPS's NTM/LTM revenue growth is n/a
Farminveste SGPS's revenue per employee for the last fiscal year averaged $159M, while opex per employee averaged n/a for the same period.
Over next 12 months, Farminveste SGPS's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Farminveste SGPS's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Farminveste SGPS and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | XXX | XXX | XXX |
| EBITDA Margin | N/A | XXX | XXX | XXX | XXX |
| EBITDA Growth | 25% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | N/A | XXX | XXX | XXX | XXX |
| Revenue per Employee | $159M | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 0% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
| Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Farminveste SGPS acquired XXX companies to date.
Last acquisition by Farminveste SGPS was XXXXXXXX, XXXXX XXXXX XXXXXX . Farminveste SGPS acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Farminveste SGPS founded? | Farminveste SGPS was founded in 2010. |
| Where is Farminveste SGPS headquartered? | Farminveste SGPS is headquartered in Portugal. |
| How many employees does Farminveste SGPS have? | As of today, Farminveste SGPS has 6 employees. |
| Is Farminveste SGPS publicy listed? | Yes, Farminveste SGPS is a public company listed on LIS. |
| What is the stock symbol of Farminveste SGPS? | Farminveste SGPS trades under MLFMV ticker. |
| When did Farminveste SGPS go public? | Farminveste SGPS went public in 2018. |
| Who are competitors of Farminveste SGPS? | Similar companies to Farminveste SGPS include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
| What is the current market cap of Farminveste SGPS? | Farminveste SGPS's current market cap is $26.3M |
| What is the current revenue growth of Farminveste SGPS? | Farminveste SGPS revenue growth between 2023 and 2024 was 2%. |
| Is Farminveste SGPS profitable? | Yes, Farminveste SGPS is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
